{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:31:37Z","timestamp":1762864297369},"reference-count":39,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,20]],"date-time":"2001-12-20T00:00:00Z","timestamp":1008806400000},"content-version":"vor","delay-in-days":249,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Neurochemistry"],"published-print":{"date-parts":[[2001,4,15]]},"abstract":"<jats:p>The antipsychotic drugs have been shown to be inverse agonists at the D<jats:sub>2<\/jats:sub> dopamine receptor. We have examined the mechanism of this inverse agonism by making mutations in residue T343 in the base of the sixth transmembrane spanning region of the receptor. T343R, T343S and T343K mutant D<jats:sub>2<\/jats:sub> dopamine receptors were made and the T343R mutant characterized in detail. The T343R mutant D<jats:sub>2<\/jats:sub> dopamine receptor exhibits properties of a receptor that resides more in the activated state, namely increased agonist binding affinity (independent of G\u2010protein coupling and dependent on agonist efficacy), increased agonist potency in functional tests (adenylyl cyclase inhibition) and increased inverse agonist effects. The binding of agonists to the mutant receptor also shows sensitivity to sodium ions, unlike the native receptor, so that isomerization of the receptor to its inactive state may be driven by sodium ions. The binding of inverse agonists to the receptor is, however, unaffected by the mutation. We conclude that inverse agonism at this receptor is not achieved by the inverse agonist binding preferentially to the non\u2010activated state of the receptor over the activated state. Rather the inverse agonist appears to bind to all forms of the receptor but then renders the receptor inactive.<\/jats:p>","DOI":"10.1046\/j.1471-4159.2001.00233.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T06:52:39Z","timestamp":1047451959000},"page":"493-504","source":"Crossref","is-referenced-by-count":47,"title":["Mechanisms of inverse agonism of antipsychotic drugs at the D<sub>2<\/sub> dopamine receptor: use of a mutant D<sub>2<\/sub> dopamine receptor that adopts the activated conformation"],"prefix":"10.1111","volume":"77","author":[{"given":"Janet","family":"Wilson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dingyi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan A.","family":"Javitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip G.","family":"Strange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,20]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.35.22330"},{"key":"e_1_2_7_3_1","first-page":"473","article-title":"Gi protein modulation induced by a selective inverse agonist for the peripheral cannabinoid receptor CB2: implication for intracellular signalisation cross\u2010regulation","volume":"55","author":"Bouaboula M.","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1993.tb05863.x"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(73)90196-2"},{"key":"e_1_2_7_6_1","first-page":"549","article-title":"Drug effects at guanine nucleotide regulatory binding protein linked receptors: thermodyamic interpretation of negative antagonism of receptor activation in the absence of ligand","volume":"41","author":"Costa T.","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.8.2896"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701926"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.1997.69062589.x"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0701196"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.52.6.1137"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s007020050091"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(93)90048-O"},{"key":"e_1_2_7_14_1","first-page":"1024","article-title":"Multiple phosphorylation sites are required for pathway\u2010selective uncoupling of the 5\u2010hydroxytryptamine1A receptor by protein kinase C","volume":"48","author":"Lembo P. M.","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)52451-6"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2000.0740347.x"},{"key":"e_1_2_7_17_1","first-page":"790","article-title":"Characterisation of [3H]quinpirole binding to human D2A and D3 receptors: effects of ions and guanine nucleotides","volume":"274","author":"Malmberg A.","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1471-4159.2000.751283.x"},{"key":"e_1_2_7_19_1","first-page":"749","article-title":"Unique binding characteristics of antipsychotic agents interacting with the human D2A, D2B and D3 dopamine receptors","volume":"43","author":"Malmberg A.","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_7_20_1","first-page":"U9 (suppl.)","article-title":"Increase in dopamine D2 receptor and G protein levels following sodium butyrate treatment of a recombinant CHO cell line","volume":"131","author":"Marston D. L.","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-6147(97)01139-5"},{"key":"e_1_2_7_22_1","first-page":"570","article-title":"Regulation of D2 dopamine receptors by sodium and pH","volume":"39","author":"Neve K. A.","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-2635-0_2"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01244880"},{"key":"e_1_2_7_25_1","first-page":"P109","article-title":"Investigation of mechanisms of agonist action at the human Ds short dopamine receptor","volume":"126","author":"Payne S.","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"e_1_2_7_26_1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2144\/96201st05","article-title":"Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic resistant cells to express recombinant receptor","volume":"20","author":"Rees S.","year":"1996","journal-title":"Biotechniques"},{"key":"e_1_2_7_27_1","doi-asserted-by":"crossref","first-page":"16483","DOI":"10.1016\/S0021-9258(19)85445-5","article-title":"Constitutively active mutants of the alpha 2\u2010adrenergic receptor","volume":"268","author":"Ren Q.","year":"1993","journal-title":"J. Biol. Chem."},{"key":"e_1_2_7_28_1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1124\/mol.56.5.858","article-title":"Inverse agonism and neutral antagonism at \u03b11a and \u03b11b adrenergic receptor subtypes","volume":"56","author":"Rossier O.","year":"1999","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0003-2697(74)90222-X"},{"key":"e_1_2_7_30_1","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1016\/S0021-9258(18)53442-6","article-title":"A mutation\u2010induced activated state of the beta\u2010adrenergic receptor. Extending the ternary complex model","volume":"268","author":"Samama P.","year":"1993","journal-title":"J. Biol. Chem."},{"key":"e_1_2_7_31_1","first-page":"390","article-title":"Negative antagonists promote an inactive conformation of the \u03b12\u2010adrenergic receptor","volume":"45","author":"Samama P.","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-6147(92)90116-N"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi970565g"},{"key":"e_1_2_7_34_1","volume-title":"Brain Biochemistry and Brain Disorders","author":"Strange P. G.","year":"1992"},{"key":"e_1_2_7_35_1","first-page":"116","article-title":"Commentary on atypical neuroleptics","volume":"16","author":"Strange P. G.","year":"1997","journal-title":"Neurospychopharmacology"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0165-6147(98)01175-4"},{"key":"e_1_2_7_37_1","first-page":"524","article-title":"Determination of \u03b12 adrenergic receptor activation of G protein: evidence for\u00a0a precoupled receptor\/G protein state","volume":"45","author":"Tian W. N.","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.26.15485"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1985.tb10542.x"},{"key":"e_1_2_7_40_1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1124\/mol.54.2.435","article-title":"Contribution of serine residues to constitutive and agonist induced signalling via the D2s dopamine receptor: evidence for multiple agonist specific conformations","volume":"54","author":"Wiens B. L.","year":"1998","journal-title":"Mol. Pharmacol."}],"container-title":["Journal of Neurochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1471-4159.2001.00233.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1471-4159.2001.00233.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T19:43:33Z","timestamp":1697658213000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1471-4159.2001.00233.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,4,15]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,4,15]]}},"alternative-id":["10.1046\/j.1471-4159.2001.00233.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00233.x","archive":["Portico"],"relation":{},"ISSN":["0022-3042","1471-4159"],"issn-type":[{"value":"0022-3042","type":"print"},{"value":"1471-4159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,4,15]]}}}